Glymphatic Drainage, Alzheimer's Disease, and How to Protect Your Brain. part 2
Author: David S. Klein, MD, FACA, FACPM, FAAMIMS Stages of Life Medical Institute | Brain Health, Sleep & Longevity
Focus keywords: glymphatic drainage, Alzheimer's prevention, deep sleep, brain waste clearance, sleep apnea, amyloid-beta, tau protein, brain health
Quick Look
Could poor sleep interfere with your brain's ability to remove metabolic waste? Emerging research suggests that sleep, vascular health, and cerebrospinal fluid movement are closely connected. Scientists are investigating whether dysfunction of the glymphatic system contributes to Alzheimer's disease and cognitive decline. Although promising, this research has not yet established that enhancing glymphatic drainage prevents dementia.
What Happens When the Brain's Waste-Removal System Becomes Less Efficient?
In Part 1, we explored an intriguing discovery: during sleep, the spaces between brain cells may change, potentially facilitating the movement of cerebrospinal fluid through brain tissue.
This process is associated with the glymphatic system, a proposed network of fluid-exchange pathways that helps transport metabolic substances through and away from the brain.
But what happens when these processes become less efficient?
Could years of disrupted sleep contribute to the accumulation of proteins associated with Alzheimer's disease?
And perhaps most importantly, can we do anything to improve glymphatic function?
These questions have generated considerable excitement in neuroscience. They have also produced scientific controversy.
The evidence suggests that sleep, cerebrovascular function, and neurological health are interconnected. However, understanding that relationship requires distinguishing established clinical findings from emerging experimental hypotheses.
The Relationship Between Glymphatic Drainage and Alzheimer's Disease
Alzheimer's disease is characterized by several pathological changes, including the accumulation of amyloid-beta plaques and abnormal tau proteins.
Amyloid-beta is produced during normal neuronal activity. Under healthy conditions, its concentration is regulated through multiple mechanisms, including enzymatic degradation, cellular uptake, transport across the blood-brain barrier, and fluid-mediated clearance.
Tau is a protein that normally helps stabilize the internal structure of neurons. In Alzheimer's disease, abnormal forms of tau accumulate within neurons and contribute to neurofibrillary tangles.
Researchers have proposed that impaired glymphatic transport might contribute to the accumulation of these substances.¹
Animal experiments provide evidence that cerebrospinal fluid and interstitial fluid exchange can influence the movement of amyloid-beta.
Human studies have also demonstrated associations between sleep disruption and changes in amyloid-beta and tau biomarkers.
For example, an experimental study published in PNAS found that one night of sleep deprivation was associated with increased amyloid-beta signal in certain human brain regions on PET imaging.²
Another study demonstrated that experimentally disrupting slow-wave sleep increased cerebrospinal fluid amyloid-beta concentrations.³
These findings suggest that sleep physiology influences the metabolism and distribution of proteins associated with Alzheimer's disease.
However, increased protein concentration does not necessarily prove that glymphatic clearance has failed. Protein production, release, degradation, and transport can all influence measured concentrations.
Furthermore, Alzheimer's pathology can itself interfere with sleep, creating a potentially bidirectional relationship.
The clinical implications are important, but the causal pathways remain incompletely understood.
Why Aging May Affect Glymphatic Function
Aging is associated with changes in cerebral blood vessels, sleep architecture, astrocyte function, and cerebrospinal fluid dynamics. Several of these changes may influence glymphatic transport.
1. Reduced deep sleep
Older adults often spend less time in slow-wave sleep than younger individuals.
Because slow-wave sleep is associated with distinctive patterns of neuronal activity, cerebral blood flow, and cerebrospinal fluid movement, these changes may affect brain fluid physiology.
2. Changes in blood vessel function
Cerebral arteries become less compliant with age, particularly in people with hypertension, diabetes, or atherosclerotic disease.
Vascular pulsations and slow changes in vascular diameter may contribute to fluid movement around blood vessels.
Age-related vascular dysfunction could therefore influence perivascular transport.
3. Changes in aquaporin-4 organization
Aquaporin-4 (AQP4) is a water-channel protein concentrated in astrocytic endfeet surrounding cerebral blood vessels.
Experimental studies suggest that the spatial organization of these channels may influence fluid exchange.
Animal research has associated aging with altered AQP4 localization and reduced measures of glymphatic transport.⁴
Whether these mechanisms can be therapeutically modified to prevent human cognitive decline remains uncertain.
How Magnesium L-Threonate Helps
Brain delivery: It effectively crosses the blood-brain barrier, raising magnesium levels inside the brain better than forms like citrate or glycinate.
Deeper sleep: It promotes restorative slow-wave delta sleep, which directly triggers the fluid flow needed for waste removal.
Nervous system calm: It supports healthy neurotransmitter signaling and reduces stress, making it easier to transition into the deep sleep stages required for brain detoxification.
Sleep Apnea: An Important and Treatable Threat to Brain Health
Obstructive sleep apnea deserves particular attention.
During an obstructive apnea, airflow is reduced or interrupted despite continued respiratory effort.
These episodes can produce intermittent hypoxemia, fluctuations in intrathoracic pressure, sympathetic nervous system activation, and repeated sleep fragmentation.
Over time, untreated sleep apnea may contribute to hypertension, cardiovascular disease, metabolic dysfunction, and impaired daytime cognitive performance.
Investigators are also studying whether sleep apnea alters glymphatic physiology through changes in respiration, cerebral venous pressure, vascular function, and sleep architecture.
These proposed mechanisms are biologically plausible, but direct evidence that treating sleep apnea restores glymphatic waste clearance in humans is still limited.
Nevertheless, treating clinically significant obstructive sleep apnea is important for established reasons, independent of the glymphatic hypothesis.
Clinical Pearl
A patient who sleeps eight hours but experiences repeated apneas may obtain substantially less restorative sleep than the clock suggests.
Persistent snoring, witnessed breathing pauses, morning headaches, and daytime sleepiness warrant evaluation. Treating sleep apnea can improve symptoms and selected cardiovascular outcomes, even though a specific dementia-prevention benefit has not been established.
Does Sleeping Position Affect Brain Drainage?
One of the more interesting questions concerns whether sleeping on your side helps the brain remove metabolic waste.
A 2015 animal study compared fluid transport in different sleeping positions.
The investigators reported more favorable glymphatic transport measures in the lateral position than in the supine or prone positions under their experimental conditions.⁵
These findings attracted considerable attention because side sleeping is common among humans.
However, several limitations are important. The study was performed in anesthetized rodents rather than naturally sleeping humans.
Body position may also influence respiration, venous drainage, intracranial pressure, and other physiological variables.
Although lateral sleeping may benefit some patients with positional obstructive sleep apnea, there is insufficient clinical evidence to recommend a particular sleeping position specifically to enhance glymphatic clearance or prevent Alzheimer's disease.
The most appropriate position depends on individual factors, including respiratory disorders, musculoskeletal conditions, reflux, and comfort.
Can Sleeping Medications Interfere With Glymphatic Drainage?
This question is especially important because sedation and physiological sleep are not necessarily equivalent.
Natural sleep involves coordinated changes in electrical activity, neurotransmitter release, vascular function, and hormonal regulation.
Different medications alter these processes in different ways.
Benzodiazepines, nonbenzodiazepine hypnotics, sedating antihistamines, and other medications may produce sleepiness or unconsciousness without reproducing every feature of normal sleep architecture.
In a 2025 mouse study published in Cell, investigators found that norepinephrine-related vascular oscillations were associated with glymphatic fluid movement during sleep.⁶
The investigators also reported that zolpidem suppressed some of these oscillations and reduced associated glymphatic activity in their experimental model.
This is an important mechanistic observation.
It does not establish that zolpidem causes Alzheimer's disease or that all sleeping medications impair glymphatic clearance in humans.
Clinical decisions about hypnotic medications should instead consider established issues such as falls, cognitive side effects, dependence, respiratory suppression, drug interactions, and individual treatment benefits.
Patients should not abruptly discontinue prescribed sedative medications because of glymphatic research findings.
Can Exercise Improve Glymphatic Function?
Physical activity supports brain health through several well-established mechanisms.
Exercise improves cardiovascular fitness, insulin sensitivity, endothelial function, and metabolic regulation. It may also improve sleep quality and reduce some risk factors associated with cognitive decline.
Animal studies suggest that exercise can influence glymphatic transport, potentially through vascular and astrocytic mechanisms.
However, the degree to which exercise enhances glymphatic clearance in humans has not been established.
The strongest evidence-based recommendation is to exercise for overall cardiovascular, metabolic, and neurological health rather than to target an unvalidated glymphatic outcome.
For many adults, a reasonable goal is approximately 150 minutes of moderate-intensity aerobic activity per week, supplemented by resistance training when medically appropriate.
The Role of Insulin Resistance and Metabolic Health
The brain is highly sensitive to vascular and metabolic disturbances.
Insulin resistance is associated with endothelial dysfunction, systemic inflammation, hypertension, and an increased risk of type 2 diabetes.
These conditions can influence cerebral microvascular function and may contribute to cognitive impairment.
Because glymphatic transport appears to interact with vascular physiology, researchers are examining whether metabolic dysfunction affects brain fluid exchange.
The proposed relationship is intriguing but remains incompletely established in humans.
Improving insulin sensitivity, controlling blood pressure, and addressing dyslipidemia are already important strategies for reducing vascular risk.
They should not be described as proven methods of accelerating glymphatic clearance.
Can Supplements Improve Glymphatic Drainage?
Interest in the glymphatic system has generated claims about numerous supplements, including glycine, magnesium, melatonin, omega-3 fatty acids, and various antioxidant preparations.
Some of these compounds have legitimate physiological roles.
For example, glycine participates in inhibitory neurotransmission and thermoregulation. Small clinical studies suggest that supplemental glycine may improve certain subjective sleep outcomes.
Magnesium is involved in neuronal signaling and muscle function, while melatonin contributes to circadian timing.
Omega-3 fatty acids are important components of neuronal membranes.
However, evidence that supplementing these substances directly enhances glymphatic waste clearance in humans is insufficient.
A supplement that improves sleep quality does not necessarily increase amyloid-beta or tau elimination.
Likewise, a substance that changes glymphatic tracer movement in rodents should not automatically be considered a treatment for human neurodegenerative disease.
The distinction between biological plausibility and demonstrated clinical benefit is essential.
What About Dehydration?
Because cerebrospinal fluid is primarily water, it may seem logical that drinking more water would improve glymphatic drainage.
Unfortunately, the physiology is not that simple.
Cerebrospinal fluid production and circulation are regulated by complex mechanisms involving the choroid plexus, vascular physiology, osmotic gradients, and fluid homeostasis.
Adequate hydration is important, especially in older adults who may have impaired thirst perception or take diuretics.
However, there is no convincing clinical evidence that drinking water beyond normal physiological requirements enhances glymphatic clearance.
Excessive water intake can also be dangerous, particularly in patients susceptible to hyponatremia or fluid overload.
The Most Practical Ways to Protect Your Brain
While glymphatic research continues, patients can take meaningful steps to support neurological health.
Intervention | Established benefit | Glymphatic evidence |
Consistent, adequate sleep | Supports cognitive performance and general health | Promising, mechanism still debated |
Treating sleep apnea | Improves symptoms and selected health outcomes | Direct clearance benefit unproven |
Regular exercise | Improves vascular and metabolic health | Primarily preclinical |
Managing hypertension | Reduces stroke and cardiovascular risk | Indirect mechanistic evidence |
Improving insulin resistance | Reduces metabolic and vascular risk | Human clearance benefit unproven |
Side sleeping | May improve positional sleep apnea | Mainly animal evidence |
Glycine or other supplements | May help selected sleep-related symptoms | No proven human clearance benefit |
The most reasonable strategy is to support healthy sleep and cardiovascular physiology while avoiding claims that exceed the available evidence.
Frequently Asked Questions
Can poor sleep cause Alzheimer's disease?
Chronic sleep disruption is associated with cognitive decline and dementia risk in observational studies. However, it is difficult to separate causation from the possibility that early neurological disease itself disrupts sleep.
Can glymphatic drainage be measured?
Researchers use MRI-based techniques, tracer studies, and other experimental methods to investigate cerebral fluid transport. No single noninvasive clinical test has been universally validated to measure total glymphatic waste clearance in humans.
Is deep sleep more important than REM sleep for glymphatic function?
Slow-wave sleep has been associated with distinctive cerebral fluid dynamics. However, the contributions of different sleep stages to overall waste clearance remain under investigation.
Should everyone sleep on their side?
No. Side sleeping may help certain patients with positional sleep apnea, but there is insufficient evidence that it prevents dementia by enhancing glymphatic drainage.
Can glymphatic dysfunction be reversed?
Experimental research suggests that some factors influencing brain fluid transport may be modifiable. Reliable clinical methods for reversing glymphatic dysfunction in humans have not yet been established.
Bottom Line
The glymphatic system has changed how scientists think about the sleeping brain.
Research suggests that sleep, vascular activity, cerebrospinal fluid movement, and metabolic waste transport are closely interconnected.
These discoveries may eventually contribute to new approaches for understanding and treating neurodegenerative disease.
However, the scientific evidence does not yet justify claims that particular supplements, sleeping positions, or medications can reliably accelerate brain detoxification or prevent Alzheimer's disease.
For now, the most effective strategy is to protect the physiological foundations of brain health: restorative sleep, regular exercise, healthy vascular function, metabolic stability, and appropriate treatment of sleep disorders.
The brain's nighttime housekeeping system may prove to be one of the most important discoveries in sleep neuroscience—but we are still learning how it works.
Continue Your Journey to Better Health
At Stages of Life Medical Institute, we believe that preserving brain health requires looking beyond individual symptoms. Sleep, vascular health, insulin resistance, nutrition, and inflammation interact in ways that may influence neurological aging. The following published articles explore these connections and provide additional guidance for protecting cognitive and metabolic health.
1. L-Glycine: An Overlooked Amino Acid for Sleep, Anxiety, Recovery, and Longevity — Learn how glycine may support sleep quality, thermoregulation, and recovery. Particularly relevant to understanding restorative sleep and its potential relationship to glymphatic physiology.
Stages of Life
2. Vitamin D in Midlife May Reduce Future Tau Protein Burden: Implications for Dementia Prevention — Explore research associating midlife vitamin D status with later tau accumulation, an important feature of Alzheimer's pathology.
Stages of Life
3. Could You Be Running Low on Glycine? — Examine glycine's roles in glutathione production, mitochondrial function, metabolic resilience, and sleep regulation, with attention to the limitations of supplementation evidence.
Stages of Life
4. Pre-Diabetes: Insulin Resistance, Is It a Real Condition — Or a Warning Sign We Ignore at Our Own Risk? — Understand how insulin resistance may influence vascular health and neurological aging long before diabetes develops.
Stages of Life
5. Your Fasting Glucose Is Normal—but Is Your Insulin? — Learn why apparently normal glucose levels can coexist with metabolic dysfunction and why early recognition of insulin resistance may matter for long-term health.
Stages of Life
6. Sleep Time. No Side Effects. Reasonably Priced. — Explore nutritional approaches to sleep and the importance of evaluating their benefits, limitations, and potential medication interactions.
Stages of Life
Become a Patient
At Stages of Life Medical Institute, our approach to healthy aging includes evaluating sleep disturbances, metabolic dysfunction, nutritional status, cardiovascular risk, and other potentially modifiable contributors to cognitive health.
Stages of Life Medical Institute 1917 Boothe Circle, Longwood, Florida 32750 Telephone: 407-679-3337
Scientific References
Iliff JJ, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4:147ra111. PubMed
Shokri-Kojori E, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci USA. 2018;115:4483–4488. PubMed
Ju Y-ES, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain. 2017;140:2104–2111. PubMed
Kress BT, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76:845–861. PubMed
Lee H, et al. The effect of body posture on brain glymphatic transport. J Neurosci. 2015;35:11034–11044. PubMed
Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep. Cell. 2025. Original publication
Medical Disclaimer: This article is intended for educational purposes and does not replace individualized medical evaluation, diagnosis, or treatment. Patients should consult their healthcare professional before changing prescribed medications or beginning supplements.© 2026 Stages of Life Medical Institute. All rights reserved.
The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances.
1917 Boothe Circle, Suite 171
Longwood, Florida 32750
Tel: 407-679-3337
Fax: 407-678-7246
.webp)